KISSEI PHARMACEUTICAL CO.,LTD. [4547.T]
TOKYO, Jun 03 (Pulse News Wire) – Kissei Pharmaceutical CO.,LTD. (4547.T) reported today that it did not purchase any shares during the period from May 12 to May 31, 2026, under its share repurchase program.
According to the company's announcement, the total amount spent was ¥0. The board of directors had approved up to 1,489,000 ordinary shares for repurchase, representing approximately 2.2% of outstanding shares excluding treasury stock. The budget allocated for the repurchase was set at ¥20.83 billion.
In detail, the company’s resolution dated May 11, 2026, authorized the repurchase of up to 1,489,000 ordinary shares through open market purchases on the Tokyo Stock Exchange until June 30, 2026. The methods included ToSTNeT-3 off-market transactions and purchases based on a discretionary agreement for market buybacks. As of May 31, 2026, the company had cumulatively purchased 0 shares with a total expenditure of ¥0.
🟡 Confidence: Standard AI-translated content.